<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39453932</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Impact of marginalization on characteristics and healthcare utilization among people with substance use disorder in Ontario, Canada, before and during the COVID-19 pandemic: A cross-sectional study.</ArticleTitle><Pagination><StartPage>e0312270</StartPage><MedlinePgn>e0312270</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0312270</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0312270</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe and compare the characteristics of people with SUD and their use of healthcare services in two ways: 1) across varying levels of marginalization and 2) before and during the pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a population-based cross-sectional study using administrative data from Ontario, Canada. We included individuals age 16+ with a recorded diagnosis of SUD between June 2018-2019 (pre-pandemic) and June 2021-2022 (during-pandemic). Baseline sociodemographic and clinical characteristics and use of healthcare services were enumerated across the five quintiles of the Ontario Marginalization Index.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">259,497 pre-pandemic and 276,459 during-pandemic people with SUD were identified. Over 40% belonged to the two highest marginalization quintiles (Q4/Q5). Most had an outpatient visit with similar percentages across quintiles, however the number of visits increased with increasing marginalization (pre-pandemic: mean 8.5 visits in Q1 vs 13.0 visits in Q5; during-pandemic: mean 9.5 in Q1 vs 13.4 in Q5). There was no consistent pattern in percent of people who sought alcohol-related outpatient care, however more marginalized people sought drug-related outpatient care (pre-pandemic: 19.1% in Q1 vs 31.7% in Q5; during-pandemic: 18.7% in Q1 vs 32.5% in Q5). Almost half of people with SUD had an emergency department (ED) visit, of which more belonged to higher marginalization quintiles (pre-pandemic: 43.5% in Q1 vs 49.8% in Q5; during-pandemic: 41.4% in Q1 vs 49.3% in Q5).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">SUD prevalence and most health service utilization remained similar from pre- to during-pandemic. Increasing marginalization was associated with increased use of healthcare among people with SUD. Future research should aim to further explore the complex relationship between marginalization and substance use.</AbstractText><CopyrightInformation>Copyright: © 2024 Chu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Cherry</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4072-0083</Identifier><AffiliationInfo><Affiliation>Women's College Hospital Institute for Health System Solutions and Virtual Care, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Bilal</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-2120-6019</Identifier><AffiliationInfo><Affiliation>Women's College Hospital Institute for Health System Solutions and Virtual Care, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiruchelvam</LastName><ForeName>Deva</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brual</LastName><ForeName>Janette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Women's College Hospital Institute for Health System Solutions and Virtual Care, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abejirinde</LastName><ForeName>Ibukun-Oluwa Omolade</ForeName><Initials>IO</Initials><AffiliationInfo><Affiliation>Women's College Hospital Institute for Health System Solutions and Virtual Care, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kthupi</LastName><ForeName>Altea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Women's College Hospital Institute for Health System Solutions and Virtual Care, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tadrous</LastName><ForeName>Mina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1911-6129</Identifier><AffiliationInfo><Affiliation>Women's College Hospital Institute for Health System Solutions and Virtual Care, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019966" MajorTopicYN="Y">Substance-Related Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="Y">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062487" MajorTopicYN="N">Social Marginalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>22</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>22</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39453932</ArticleId><ArticleId IdType="pmc">PMC11508079</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0312270</ArticleId><ArticleId IdType="pii">PONE-D-24-01323</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Government of Canada. About substance use 2023 [updated March 13; cited 2023 September 19]. https://www.canada.ca/en/health-canada/services/substance-use/about-substance-use.html.</Citation></Reference><Reference><Citation>Canadian Mental Health Association. Substance use and addiction 2023 [cited 2023 September 19]. https://ontario.cmha.ca/addiction-and-substance-use-and-addiction/.</Citation></Reference><Reference><Citation>Canadian Centre on Substance Use and Addiction. Canadian Drug Trends 2023 [cited 2023 September 19]. https://www.ccsa.ca/canadian-drug-trends.</Citation></Reference><Reference><Citation>Canadian Centre on Substance Use and Addiction. Alcohol (Canadian Drug Summary) 2019 [cited 2023 September 19]. https://www.ccsa.ca/alcohol-canadian-drug-summary.</Citation></Reference><Reference><Citation>Dubois S. Record number of people died from alcohol and drug use during the pandemic: StatsCan. CBC News. 2023.</Citation></Reference><Reference><Citation>Canadian Centre on Substance Use and Addiction. Opioids (Canadian Drug Summary) 2022 [cited 2023 September 19]. https://www.ccsa.ca/opioids-canadian-drug-summary.</Citation></Reference><Reference><Citation>Canadian Centre on Substance Use and Addiction. Opioids 2023 [cited 2023 September 19]. https://www.ccsa.ca/opioids#:~:text=Between%20January%202016%20and%20September,public%20health%20and%20safety%20concern.</Citation></Reference><Reference><Citation>Esmaeelzadeh S, Moraros J, Thorpe L, Bird Y. Examining the Association and Directionality between Mental Health Disorders and Substance Use among Adolescents and Young Adults in the U.S. and Canada-A Systematic Review and Meta-Analysis. J Clin Med. 2018;7(12). doi: 10.3390/jcm7120543 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm7120543</ArticleId><ArticleId IdType="pmc">PMC6306768</ArticleId><ArticleId IdType="pubmed">30551577</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham K, Cheng J, Bernards S, Wells S, Rehm J, Kurdyak P. How Much Do Mental Health and Substance Use/Addiction Affect Use of General Medical Services? Extent of Use, Reason for Use, and Associated Costs. Can J Psychiatry. 2017;62(1):48–56. doi: 10.1177/0706743716664884 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0706743716664884</ArticleId><ArticleId IdType="pmc">PMC5302109</ArticleId><ArticleId IdType="pubmed">27543084</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Centre on Substance Use and Addiction. Mental Health and Substance Use During COVID-19 2023 [cited 2023 September 19]. https://www.ccsa.ca/mental-health-and-substance-use-during-covid-19.</Citation></Reference><Reference><Citation>Mougharbel F, Sampasa-Kanyinga H, Heidinger B, Corace K, Hamilton HA, Goldfield GS. Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic. Front Public Health. 2021;9:680028. doi: 10.3389/fpubh.2021.680028 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.680028</ArticleId><ArticleId IdType="pmc">PMC8270652</ArticleId><ArticleId IdType="pubmed">34249844</ArticleId></ArticleIdList></Reference><Reference><Citation>Walley AY, Paasche-Orlow M, Lee EC, Forsythe S, Chetty VK, Mitchell S, et al.. Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis. J Addict Med. 2012;6(1):50–6. doi: 10.1097/ADM.0b013e318231de51 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ADM.0b013e318231de51</ArticleId><ArticleId IdType="pmc">PMC6034987</ArticleId><ArticleId IdType="pubmed">21979821</ArticleId></ArticleIdList></Reference><Reference><Citation>Cederbaum JA, Guerrero EG, Mitchell KR, Kim T. Utilization of emergency and hospital services among individuals in substance abuse treatment. Substance Abuse Treatment, Prevention, and Policy. 2014;9(1):16. doi: 10.1186/1747-597X-9-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1747-597X-9-16</ArticleId><ArticleId IdType="pmc">PMC3992150</ArticleId><ArticleId IdType="pubmed">24708866</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth RG, Richard L, Li L, Shariff SZ, Rayner J. Characteristics of health care related to mental health and substance use disorders among Community Health Centre clients in Ontario: a population-based cohort study. CMAJ Open. 2020;8(2):E391–E9. doi: 10.9778/cmajo.20190089 .</Citation><ArticleIdList><ArticleId IdType="doi">10.9778/cmajo.20190089</ArticleId><ArticleId IdType="pmc">PMC7252687</ArticleId><ArticleId IdType="pubmed">32447281</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes T, McCormack D, Bozinoff N, Tadrous M, Antoniou T, Munro C, et al.. Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study. Addiction. 2022;117(7):1972–81. doi: 10.1111/add.15862 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/add.15862</ArticleId><ArticleId IdType="pmc">PMC9313829</ArticleId><ArticleId IdType="pubmed">35257434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledlie S, Tadrous M, Bayoumi AM, McCormack D, Cheng C, Besharah J, et al.. Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysis. International Journal of Drug Policy. 2024;127:104392. doi: 10.1016/j.drugpo.2024.104392</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugpo.2024.104392</ArticleId><ArticleId IdType="pubmed">38522177</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson FI, van Ingen T, Moloney G. 2021 Ontario Marginalization Index: User Guide. Toronto, Ontario: 2023.</Citation></Reference><Reference><Citation>Baptiste-Roberts K, Hossain M. Socioeconomic Disparities and Self-reported Substance Abuse-related Problems. Addict Health. 2018;10(2):112–22. doi: 10.22122/ahj.v10i2.561 .</Citation><ArticleIdList><ArticleId IdType="doi">10.22122/ahj.v10i2.561</ArticleId><ArticleId IdType="pmc">PMC6494986</ArticleId><ArticleId IdType="pubmed">31069035</ArticleId></ArticleIdList></Reference><Reference><Citation>McNaughton CC. Transitions through homelessness, substance use, and the effect of material marginalization and psychological trauma. Drugs: Education, Prevention and Policy. 2008;15(2):177–88. doi: 10.1080/09687630701377587</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09687630701377587</ArticleId></ArticleIdList></Reference><Reference><Citation>Benner AD, Wang Y. Adolescent substance use: The role of demographic marginalization and socioemotional distress. Dev Psychol. 2015;51(8):1086–97. doi: 10.1037/dev0000026 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/dev0000026</ArticleId><ArticleId IdType="pmc">PMC4516632</ArticleId><ArticleId IdType="pubmed">26075631</ArticleId></ArticleIdList></Reference><Reference><Citation>Otiniano Verissimo AD, Gee GC, Grella C. Examining the relationship between intersectional discrimination and substance use disorders by race/ethnicity and gender. Cultur Divers Ethnic Minor Psychol. 2023. Epub 2023/05/18. doi: 10.1037/cdp0000599 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/cdp0000599</ArticleId><ArticleId IdType="pubmed">37199958</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics Canada. Disaggregated trends in poverty from the 2021 Census of Population 2022 [cited 2023 September 22]. https://www12.statcan.gc.ca/census-recensement/2021/as-sa/98-200-X/2021009/98-200-X2021009-eng.cfm.</Citation></Reference><Reference><Citation>Havranek EP, Mujahid MS, Barr DA, Blair IV, Cohen MS, Cruz-Flores S, et al.. Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2015;132(9):873–98. Epub 2015/08/05. doi: 10.1161/CIR.0000000000000228 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000228</ArticleId><ArticleId IdType="pubmed">26240271</ArticleId></ArticleIdList></Reference><Reference><Citation>Shadmi E. Disparities in multiple chronic conditions within populations. J Comorb. 2013;3(Spec Issue):45–50. doi: 10.15256/joc.2013.3.24 .</Citation><ArticleIdList><ArticleId IdType="doi">10.15256/joc.2013.3.24</ArticleId><ArticleId IdType="pmc">PMC5636025</ArticleId><ArticleId IdType="pubmed">29090147</ArticleId></ArticleIdList></Reference><Reference><Citation>Moynihan R, Sanders S, Michaleff ZA, Scott AM, Clark J, To EJ, et al.. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021;11(3):e045343. doi: 10.1136/bmjopen-2020-045343 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-045343</ArticleId><ArticleId IdType="pmc">PMC7969768</ArticleId><ArticleId IdType="pubmed">33727273</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed OC, deRuiter WK, Buckley L, Selby P. Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments. Psychiatric Clinics. 2022;45(1):95–107. doi: 10.1016/j.psc.2021.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psc.2021.11.006</ArticleId><ArticleId IdType="pmc">PMC8585604</ArticleId><ArticleId IdType="pubmed">35219445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ontario Ministry of Health. Get coverage for prescription drugs 2023 [cited 2023 September 22]. https://www.ontario.ca/page/get-coverage-prescription-drugs#section-1.</Citation></Reference><Reference><Citation>Lau B, Tadrous M, Chu C, Hardcastle L, Beall R, F. COVID-19 and the prevalence of drug shortages in Canada: a cross-sectional time-series analysis from April 2017 to April 2022. Canadian Medical Association Journal. 2022;194(23):E801. doi: 10.1503/cmaj.212070</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.212070</ArticleId><ArticleId IdType="pmc">PMC9262135</ArticleId><ArticleId IdType="pubmed">35697373</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiles NJ, Lingford-Hughes A, Daniel J, Hickman M, Farrell M, Macleod J, et al.. Socio-economic status in childhood and later alcohol use: a systematic review*. Addiction. 2007;102(10):1546–63. doi: 10.1111/j.1360-0443.2007.01930.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1360-0443.2007.01930.x</ArticleId><ArticleId IdType="pubmed">17680850</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins SE. Associations Between Socioeconomic Factors and Alcohol Outcomes. Alcohol Res. 2016;38(1):83–94. .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4872618</ArticleId><ArticleId IdType="pubmed">27159815</ArticleId></ArticleIdList></Reference><Reference><Citation>Boardman JD, Finch BK, Ellison CG, Williams DR, Jackson JS. Neighborhood disadvantage, stress, and drug use among adults. J Health Soc Behav. 2001;42(2):151–65. Epub 2001/07/27. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11467250</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. Alcohol Use During the COVID-19 Pandemic 2023 [cited 2023 September 24]. https://covid19.nih.gov/news-and-stories/alcohol-use-during-covid-19-pandemic.</Citation></Reference><Reference><Citation>van Ingen T, Matheson FI. The 2011 and 2016 iterations of the Ontario Marginalization Index: updates, consistency and a cross-sectional study of health outcome associations. Canadian Journal of Public Health. 2022;113(2):260–71. doi: 10.17269/s41997-021-00552-1</Citation><ArticleIdList><ArticleId IdType="doi">10.17269/s41997-021-00552-1</ArticleId><ArticleId IdType="pmc">PMC8975983</ArticleId><ArticleId IdType="pubmed">34432255</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>